Corrections:
Correction: Activation of PI3K/Akt/mTOR signaling in the tumor stroma drives endocrine therapy-dependent breast tumor regression
Metrics: PDF 25 views | ?
1 Instituto de Biología y Medicina Experimental, Protein Kinases and Cancer Laboratory, Buenos Aires, Argentina
2 Mayo Clinic Comprehensive Cancer Center, Department of Cancer Biology, Jacksonville, FL, USA
3 Centro Oncológico Riojano Integral, Medical Oncology, La Rioja, Argentina
4 Department of Medical Oncology, Mayo Clinic, Rochester, MN, USA
5 Department of Surgery, Mayo Clinic, Rochester, MN, USA
Published: May 20, 2025
Copyright: © 2025 Polo et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This article has been corrected:
The authors discovered duplication errors in Figure 4 and Figure 6. Specifically, in Figure 4B top panel, tumor images stained with pS6 and representing WORT and MFP+WORT-treated tumors were found to overlap. The authors have replaced this panel with new images of the pS6 stained samples from the original experiment.
In Figure 6A there was a duplication of S6 WB images due to an incorrectly labeled picture for T47D cells. The authors have corrected this by using one of two additional sets of T47D WBs from the original experiment and replacing all panels for T47D cells. Uncropped images of two sets of T47D WBs from the original experiments have been provided.
In Figure 6D, an inadvertent duplication of IHC images for pS6 in T47D-myrAkt1 tumors treated with RAPA or RAPA+MFP (bottom right images) was present. The immunostaining was repeated using the same paraffin-embedded tissues from the original experiment, and unmodified data has been provided. with RAPA or RAPA+MFP (bottom right images) was present. The immunostaining was repeated using the same paraffin-embedded tissues from the original experiment, and unmodified data has been provided.
The authors have stated that these corrections do not alter the article's conclusions. They sincerely apologize for any inconvenience caused to the readers.
Original article: Oncotarget. 2015; 6:22081-22097. DOI:https://doi.org/10.18632/oncotarget.4203.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 28728